Walking and Bone Health Study for SMA
Part of Brain & nervous system, Genetic & congenital, Injuries & trauma clinical trials.
This study looks at walking and bone health in people with spinal muscular atrophy (SMA). It helps researchers understand how SMA affects your gait (the way you walk) and your bones, which could lead to better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with 5q spinal muscular atrophy (SMA), which is the most common type.
- You are between 8 and 50 years old.
- You can walk 10 meters (about 30 feet) without anyone's help or a device like a cane or walker.
- You haven't had any injury or surgery in the past 3 months that would stop you from doing walking tests.
- You are willing to follow all study steps and procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how children and teens with Duchenne muscular dystrophy (DMD) or spinal muscular atrophy (SMA) walk, by having them do walking tests while wearing sensors. The goal is to find better ways to track how these diseases progress and how treatments work over time, without needing blood tests or scans.
This study tests a combination of a robotic walking device (exoskeleton) and a mild electrical stimulation on the back to see if it can strengthen bones in people with spinal cord injuries. It aims to help you sit and stand more safely and improve your overall health.
This study tests whether using a powered walking exoskeleton together with a mild spinal cord stimulation device can improve muscle and bone strength in people with long-term spinal cord injuries. If you qualify, you'd use the exoskeleton during therapy sessions while researchers watch for changes in your leg muscles and bones.
This study watches how people with certain muscle or nerve diseases walk over time. It may help doctors understand changes in walking patterns and is open to adults who can walk and have a genetic diagnosis of a neuromuscular condition.
This study tests a portable device that analyzes walking without markers. It aims to see if it can help assess walking in people with neuromuscular diseases and healthy volunteers, which could lead to simpler check-ups.
This study uses motion analysis to understand walking and arm function in adults with certain neurological or metabolic diseases. The goal is to find patterns that help doctors better manage these conditions.
Hear when a new Spinal Muscular Atrophy Type 3 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.